Revenue and Profit Growth
Sonic Healthcare reported revenue of $4.669 billion, up 8% year-over-year. EBITDA increased by 12% to $827 million, and net profit rose 17% to $237 million.
Strong Cash Generation
The company generated strong operating cash flow of $620 million, which is up 37% on the prior period.
Margin Expansion
EBITDA margin increased by 60 basis points, and excluding recent acquisitions, the margin expansion was 90 basis points.
Successful M&A Activity
The acquisition of LADR in Germany, expected to add over AUD 80 million in EBITDA, and other acquisitions in Switzerland and Germany are on track with synergy initiatives.
Australian Pathology Division Performance
The division showed strong organic revenue growth of 9% and significant progress in genetics and private billing initiatives.
UK Growth and Contract Wins
The UK division reported 10% growth with notable contract wins, including Hertfordshire and West Essex, and a new hub lab in Watford.
Radiology Division Expansion
The division achieved organic revenue growth of 12% and is investing in AI solutions with plans to open new sites.